Drug companies face pressure on profitsBMJ 2002; 324 doi: https://doi.org/10.1136/bmj.324.7329.65 (Published 12 January 2002) Cite this as: BMJ 2002;324:65
- Deborah Josefson
- San Francisco
Major pharmaceutical corporations in the United States are bracing themselves for reduced profits as states, healthcare plans, and consumers lobby for lower prices for prescription drugs.
Some manufacturers are also facing the expiry of patents on some of their biggest selling drugs, which threatens to further erode their profits. Among the expected casualties are such pharmaceutical giants as Merck, Bristol-Myers Squibb, Eli Lilly, Schering-Plough, and Pharmacia.
Popular prescription brand name drugs such as …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial